SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-000860
Filing Date
2024-01-03
Accepted
2024-01-03 16:30:24
Documents
14
Period of Report
2023-12-27
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm241750d1_8k.htm   iXBRL 8-K 30799
2 EXHIBIT 16.1 tm241750d1_ex16-1.htm EX-16.1 2558
6 GRAPHIC tm241750d1_ex16-1img001.jpg GRAPHIC 3130
  Complete submission text file 0001104659-24-000860.txt   213243

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA hepa-20231227.xsd EX-101.SCH 3009
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE hepa-20231227_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hepa-20231227_pre.xml EX-101.PRE 22355
8 EXTRACTED XBRL INSTANCE DOCUMENT tm241750d1_8k_htm.xml XML 3293
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
Hepion Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36856 | Film No.: 24507014
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)